These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1183 related items for PubMed ID: 12697811

  • 41. Cell signaling switches HOX-PBX complexes from repressors to activators of transcription mediated by histone deacetylases and histone acetyltransferases.
    Saleh M, Rambaldi I, Yang XJ, Featherstone MS.
    Mol Cell Biol; 2000 Nov; 20(22):8623-33. PubMed ID: 11046157
    [Abstract] [Full Text] [Related]

  • 42. IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha.
    Giroux M, Schmidt M, Descoteaux A.
    J Immunol; 2003 Oct 15; 171(8):4187-94. PubMed ID: 14530341
    [Abstract] [Full Text] [Related]

  • 43. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y, McDonald J, Perloff E, Butticè G, Schreiber BM, Smith BD.
    Mol Immunol; 2007 Mar 15; 44(7):1709-21. PubMed ID: 16982097
    [Abstract] [Full Text] [Related]

  • 44. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
    Kitamura N, Yokoyama H, Yashiro T, Nakano N, Nishiyama M, Kanada S, Fukai T, Hara M, Ikeda S, Ogawa H, Okumura K, Nishiyama C.
    J Allergy Clin Immunol; 2012 Mar 15; 129(3):814-824.e6. PubMed ID: 22112519
    [Abstract] [Full Text] [Related]

  • 45. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.
    Montani V, Taniguchi SI, Shong M, Suzuki K, Ohmori M, Giuliani C, Napolitano G, Saji M, Fiorentino B, Reimold AM, Ting JP, Kohn LD, Singer DS.
    Endocrinology; 1998 Jan 15; 139(1):280-9. PubMed ID: 9421426
    [Abstract] [Full Text] [Related]

  • 46. Enhancement of CIITA transcriptional function by ubiquitin.
    Greer SF, Zika E, Conti B, Zhu XS, Ting JP.
    Nat Immunol; 2003 Nov 15; 4(11):1074-82. PubMed ID: 14528304
    [Abstract] [Full Text] [Related]

  • 47. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain.
    Amann JM, Nip J, Strom DK, Lutterbach B, Harada H, Lenny N, Downing JR, Meyers S, Hiebert SW.
    Mol Cell Biol; 2001 Oct 15; 21(19):6470-83. PubMed ID: 11533236
    [Abstract] [Full Text] [Related]

  • 48. Regulation of transcription factor YY1 by acetylation and deacetylation.
    Yao YL, Yang WM, Seto E.
    Mol Cell Biol; 2001 Sep 15; 21(17):5979-91. PubMed ID: 11486036
    [Abstract] [Full Text] [Related]

  • 49. X box-like sequences in the MHC class II region maintain regulatory function.
    Gomez JA, Majumder P, Nagarajan UM, Boss JM.
    J Immunol; 2005 Jul 15; 175(2):1030-40. PubMed ID: 16002703
    [Abstract] [Full Text] [Related]

  • 50. Histone deacetylase 1 (HDAC1) regulates histone acetylation, development, and gene expression in preimplantation mouse embryos.
    Ma P, Schultz RM.
    Dev Biol; 2008 Jul 01; 319(1):110-20. PubMed ID: 18501342
    [Abstract] [Full Text] [Related]

  • 51. Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes.
    Spilianakis C, Papamatheakis J, Kretsovali A.
    Mol Cell Biol; 2000 Nov 01; 20(22):8489-98. PubMed ID: 11046145
    [Abstract] [Full Text] [Related]

  • 52. mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad.
    Pal S, Yun R, Datta A, Lacomis L, Erdjument-Bromage H, Kumar J, Tempst P, Sif S.
    Mol Cell Biol; 2003 Nov 01; 23(21):7475-87. PubMed ID: 14559996
    [Abstract] [Full Text] [Related]

  • 53. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
    Liu JC, Baker RE, Chow W, Sun CK, Elsholtz HP.
    Mol Endocrinol; 2005 Jul 01; 19(7):1904-17. PubMed ID: 15731170
    [Abstract] [Full Text] [Related]

  • 54. Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines.
    Knight JS, Lan K, Subramanian C, Robertson ES.
    J Virol; 2003 Apr 01; 77(7):4261-72. PubMed ID: 12634383
    [Abstract] [Full Text] [Related]

  • 55. Adenosine signaling inhibits CIITA-mediated MHC class II transactivation in lung fibroblast cells.
    Fang M, Xia J, Wu X, Kong H, Wang H, Xie W, Xu Y.
    Eur J Immunol; 2013 Aug 01; 43(8):2162-73. PubMed ID: 23681904
    [Abstract] [Full Text] [Related]

  • 56. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M, Song Z, Gorga JC, Ksander B, Ono SJ.
    Invest Ophthalmol Vis Sci; 2004 Sep 01; 45(9):3185-95. PubMed ID: 15326139
    [Abstract] [Full Text] [Related]

  • 57. Dysregulated recruitment of the histone methyltransferase EZH2 to the class II transactivator (CIITA) promoter IV in breast cancer cells.
    Truax AD, Thakkar M, Greer SF.
    PLoS One; 2012 Sep 01; 7(4):e36013. PubMed ID: 22563434
    [Abstract] [Full Text] [Related]

  • 58. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression.
    Dhordain P, Lin RJ, Quief S, Lantoine D, Kerckaert JP, Evans RM, Albagli O.
    Nucleic Acids Res; 1998 Oct 15; 26(20):4645-51. PubMed ID: 9753732
    [Abstract] [Full Text] [Related]

  • 59. The Smad3 protein is involved in TGF-beta inhibition of class II transactivator and class II MHC expression.
    Dong Y, Tang L, Letterio JJ, Benveniste EN.
    J Immunol; 2001 Jul 01; 167(1):311-9. PubMed ID: 11418665
    [Abstract] [Full Text] [Related]

  • 60. Histone deacetylase activity is required for full transcriptional repression by mSin3A.
    Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE.
    Cell; 1997 May 02; 89(3):341-7. PubMed ID: 9150133
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 60.